Join ISPOR  | Sign up for mailing List  | Follow Us: LinkedIn Twitter Facebook YouTube

The Official Journal Of The International Society For Pharmacoeconomics And Outcomes Research

Articles in Press

Value in Health offers readers the opportunity to access complete articles (Articles in Press) to be published in upcoming issues of Value in Health. Current Articles in Press can be found at:, by clicking the “Articles in Press" tab.

Articles that appear in Articles in Press can be found in future issues of Value in Health listed below.  All articles in these future issues have been accepted for publication, and currently may be at any stage in the post-acceptance process, which include copy-editing, typesetting, author review, revisions, and pre-electronic production, with articles in earlier issues appearing sooner than articles in later issues. These accepted articles appear in Articles in Press only after completing the post-acceptance process and remain for viewing until approximately one month prior the hard copy release date (Note: The timeframe from when an article is accepted, and appears and remains in Articles in Press are approximate, pending submission to publisher, extent of typesetting, author turn-around times, revisions, etc. Thus, some accepted articles that appear below may not appear in Articles in Press).

Future Issues:

Value in Health 2014 Volume 17 Issue 8


Toward a functional definition of a 'rare disease' for regulatory authorities and funding agencies
Joe Thomas Clarke, M.D., Ph.D.; Doug Coyle, PhD; Gerald Evans, MD; Eric Winquist, MD, MSc


Mapping from the Health Assessment Questionnaire to EQ-5D: the impact of different algorithms on cost-effectiveness results
Becky Pennington, MSc, Sarah Davis, MPhys

Optimising the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysis
Rita Faria, MSc; Claire McKenna, PhD; Stephen Palmer, Professor

Economic evaluation of a cluster-randomized trial of interventions to improve health workers' practice in diagnosing and treating uncomplicated malaria in Cameroon
Lindsay Mangham-Jefferies, MA, MBA; Virginia Wisemand, PHD; Olivia A Achonduh, MPhil; Tom L Drake, MSc; Bonnie Cundill, MSc; Obinna Onwujekwe, MD, PhD; Wilfred F Mbacham, ScD

Cost-effectiveness of Telaprevir in Patients with Genotype 1 Hcv in Australia
Emma Warren; Alison Wright; Brandon Jones

Cost Effectiveness of Three Adjunct Cellular/Tissue-Derived Products used in the Management of Chronic Venous Leg Ulcers
Marissa J. Carter, PhD, MA, Curtis Waycaster, PhD, Kathleen Schaum, MS, Adrienne M. Gilligan, PhD


Conceptual Model and Economic Experiments to Explain Non-persistence and Enable Mechanism Designs Fostering Behavioral Change
Behnud Mir Djawadi, M.Sc; René Fahr, PhD; Florian Turk, PhD

Validation of the Patient Perception of Intensity of Urgency Scale (PPIUS) in Patients with Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia
Susan Mathias; Ross D Crosby; Jameel Nazir; Monique Klaver; Ted Drogendijk; Zalmai Hakimi; Isaac A Odeyemi


Parents' Willingness-to-pay for Biologic Treatments in Juvenile Idiopathic Arthritis
Heather Burnett; Wendy Ungar; Dean Regier; Brian Feldman; Fiona Miller

Economic Evaluations of Genetic Test Information for Treatable Conditions using Discrete Choice Experiments: Genetic Testing for Lynch Syndrome Phil McEwan, PhD, Volker Foos, MSc, James L. Palmer, MSc, Mark Lamotte, MD, Adam Lloyd, MPhil, David M. Grant, MBA

US Valuation of Health Outcomes Measured Using the PROMIS-29
Benjamin Matthew Craig, Ph.D.; Bryce B Reeve, PhD; Paul M Brown, PhD; David Cella, PhD; Ron D Hays, PhD; Joseph Lipscomb, PhD; A. Simon Pickard, PhD; Dennis A Revicki, PhD


Capitalizing on Prescribing Pattern Variation to Compare Medications for Type 2 Diabetes
Julia Prentice, PhD; Paul R Conlin, MD; Walid F Gellad, MD, MPH; David Edelman, MD; Todd A Lee, PharmD, PhD; Steven D Pizer, PhD


Predicting Adherence to Medications Using Health Psychology Theories: a Systematic Review of Twenty Years of Empirical Research
Emily Anne Fargher Holmes, MSc.; Dyfrig A Hughes, BPharm, MSc, PhD, FLSW; Valerie L Morrison, M.A., PhD., C.Psychol.

Does Convenience Matter in Health Care Delivery? A Systematic Review of Convenience-based Aspects of Process Utility
Ailish Higgins, MSc; Julie Barnett, PhD; Catherine Meads, MD, PhD; Jeshika Singh, MSc; Louise Longworth, PhD


Evolution of Drug Reimbursement in Canada: the Pan-canadian Pricing Alliance for New Drugs
Don Husereau; William Dempster, BA, LL.B, MA; Adrienne Blanchard, BComm, LL.B; Johanne Chambers


Performance of the Ukpds Outcomes Model for Prediction of Myocardial Infarction and Stroke in the Addition-europe Trial Cohort: Does the Addition Validation Add up?
Alastair M Gray; Rury R Holman, FRCP FMedSci; Philip M Clarke, PhD; Jose Leal, DPhil

Value in Health 2014 Volume 18 Issue 1


Can we Use Social Media to Support Content Validity of Patient Reported Outcome (PRO) Instruments in Medical Product Development? Margaret Rothman, PhD; Ari Gnanaskathy, MSc, MBA; Paul Wicks, PhD; Elektra Papadopoulos, MD, MPH


Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research - The SIMULATE Checklist: An ISPOR Emerging Good Practices Task Force Report
Deborah Marshall, PhD,  William Crown, PhD, Mitchell K. Higashi, PhD, Maarten J. IJzerman, PhD, Lina Burgos-Liz, MSc, MPH, BSc Ind Eng, Nathaniel D. Osgood, BS, MS, PhD, William V. Padula, PhD, MS, Kalyan Pasupathy, PhD, Peter K. Wong, PhD, MS, MBA, RPh


High dose haemodialysis versus conventional in-centre haemodialysis: a cost utility analysis from a United Kingdom payer perspective Frank Xiaoqing Liu; Catrin Treharne; Murat Arici; Lydia Crowe; Bruce Culleton


Using Classical Test Theory, Item Response Theory, and Rasch Measurement Theory to Evaluate Patient-Reported Outcome (PRO) Measures: A Comparison of Worked Examples Jennifer Petrillo; Stefan Cano; Lori Mcleod, PhD; Cheryl Coon

Comparing measurement properties of the EQ-5D-3L, ICECAP-O and ASCOT in frail older adults Karen M van Leeuwen, MSc; Judith E Bosmans, PhD; Aaltje P Jansen, PhD; Emiel O Hoogendijk, MSc.; Maurits W van Tulder, PhD; Henriëtte E van der Horst, PhD; Raymond W Ostelo, PhD

Measuring Health-Related Quality of Life by Experiences: The Experience Sampling Method Iris H.L. Maes, Philippe A.E.G. Delespaul, Madelon L. Peters, Mathew P. White, Yvette van Horn, Koen Schruers, Lucien Anteunis, Manuela Joore


An exploratory study to test the impact of three ‘bolt-on’ dimensions to the EQ-5D Yaling Yang (PhD), Donna Rowen (PhD), John Brazier (PhD), Aki Tsuchiya (PhD), Tracey Young (PhD), Louise Longworth (PhD)

Estimating Quality-Adjusted Life Year Loss Due to Non-Communicable Diseases in Korean adults through to the year 2040 Minsu Ock; Jung won Han; Jin Yong Lee; Seon-Ha Kim; Min-Woo Jo

Pediatricians' Preferences for Infant Meningococcal Vaccination Christine Poulos, Ph.D; F. Reed Johnson, Ph.D; Girishanthy Krishnarajah, MBA, MPH; Andrea Anonychuk, MSc; Derek Misurski, Ph.D

Physicians' Preferences for Bone Metastases Drug Therapy in the United States Jorge Arellano, M.Sc., M.Phil.; A.Brett Hauber, Ph.D.; Ateesha F Mohamed, M.A.; Juan Marcos Gonzalez, Ph.D.; Helen Collins, M.D.; Guy Hechmati, M.Sc.; Francesca Gatta, M.Sc.; Yi Qian, Ph.D.


Evaluation of patient registries supporting reimbursement decisions: The case of oxaliplatin for treatment of stage III colon cancer. Leyla Mohseninejad, MSc, Chantal van Gils, MSc, Carin A. Uyl-de Groot, PhD, Erik Buskens, MD, PhD, Talitha Feenstra, PhD


Risk Attitude and Personality Traits Predict Perceptions of Benefits and Risks for Medicinal Products: A Field Study of European Medical Assessors Andrea Beyer, MPH; Barbara Fasolo, PhD; Pieter de Graeff, MD, PhD; Hans Hillege,


Determining the impact of modelling additional sources of uncertainty in value of information analysis Isaac Corro Ramos, PhD, Maureen P. M. H. Rutten-van Mölken, Maiwenn J. Al, PhD

Measuring Change in Quality of Life: Bias in Prospective and Retrospective Evaluation Christine Blome; Matthias Augustin, university professor

Network meta-analysis: development of a 3-level hierarchical modelling approach incorporating dose-related constraints Rhiannon Kate Owen, MSc, BSc(Hons); Douglas G Tincello, BSc MBChB MD FRCOG; Keith R Abrams, BSc MSc PhD


Optimizing the Leveraging of Real World Data: How It Can Improve the Development and Use of Medicines? Marc L. Berger; Craig Lipset; Alex Gutteridge, PhD; Kirsten Axelsen; Prasun Subedi; David Madigan, PhD

Do the current performance-based schemes in Italy really work? Success fee: a novel measure for cost-containment of drug expenditure Andrea Navarria, M.D.; Valentina Drago; Lucia Gozzo, M.D.; Laura Longo; Silvana Mansueto; Giacomo Pignataro, Ph.D.; Filippo Drago, M.D., Ph.D.


Value in Health Main Page

Contact ISPOR @  |  View Legal Disclaimer
©2015 International Society for Pharmacoeconomics and Outcomes Research. All rights reserved under International and Pan-American Copyright Conventions. 
Website design by Eagle Systems USA, Inc.